高榕创投
@gaorong
创造美好生活
Articles
A Playbook for Billion-Dollar Drug Development: Navigating Uncharted Waters and Making Landfall | Ronghui
From Prozac to Gleevec — how to persevere on the long and winding road.
Soaring Across the Global Talent Pool: Ubiquitous Talent and Opportunity Through the Eyes of Global Entrepreneurs | Ronghui
Organizational development at global companies must always stay tightly aligned with the business.
A Conversation with Deel Cofounder Shuo Wang: How the Fastest-Growing SaaS Company in History Manages a Fully Remote Team Across 80+ Countries and 1,300+ Employees
It shattered global SaaS growth records — and our assumptions about what a truly globalized organization could look like.
From Big Pharma to Biotech: Four Industry Leaders on How Innovative Drugs Can Balance Speed and Quality | Ronghui
Speed matters, but getting it right matters more.
GalaxySpace Closes New Funding Round, Accelerating China's Satellite Internet Buildout
China's first unicorn in the commercial space and satellite internet sectors.
Robotics, SaaS, and innovative drug sectors close new funding rounds; chips and medical devices unveil major new products | Rongbao · August
Differentiated innovation and global opportunities.
Antibody discovery CRO **Baiying Biotech** closes nearly RMB 500 million Series B round
Specializing in antibody discovery CRO services to accelerate antibody drug development.
Global E-commerce SaaS Platform Dianxiaomi Raises $110 Million in Series D to Accelerate International Expansion
The platform has served more than 1.5 million users worldwide and processes over RMB 350 billion in annual order transaction volume.
XR chip developer GravityXR has raised tens of millions of RMB across angel and Pre-A rounds within six months
Focused on tackling XR-dedicated smart chips.
CoreVision Biopharma Closes Nearly RMB 100 Million Angel Round, Pioneering Visualized Theranostic Targeted Radiopharmaceuticals
Dedicated to becoming a trailblazer in China's TRT space.